315 related articles for article (PubMed ID: 23947294)
1. The financial burden from non-communicable diseases in low- and middle-income countries: a literature review.
Kankeu HT; Saksena P; Xu K; Evans DB
Health Res Policy Syst; 2013 Aug; 11():31. PubMed ID: 23947294
[TBL] [Abstract][Full Text] [Related]
2. Economic impacts of health shocks on households in low and middle income countries: a review of the literature.
Alam K; Mahal A
Global Health; 2014 Apr; 10():21. PubMed ID: 24708831
[TBL] [Abstract][Full Text] [Related]
3. The macroeconomic burden of noncommunicable diseases associated with air pollution in China.
Chen S; Bloom DE
PLoS One; 2019; 14(4):e0215663. PubMed ID: 30998763
[TBL] [Abstract][Full Text] [Related]
4. Estimated effect of increased diagnosis, treatment, and control of diabetes and its associated cardiovascular risk factors among low-income and middle-income countries: a microsimulation model.
Basu S; Flood D; Geldsetzer P; Theilmann M; Marcus ME; Ebert C; Mayige M; Wong-McClure R; Farzadfar F; Saeedi Moghaddam S; Agoudavi K; Norov B; Houehanou C; Andall-Brereton G; Gurung M; Brian G; Bovet P; Martins J; Atun R; Bärnighausen T; Vollmer S; Manne-Goehler J; Davies J
Lancet Glob Health; 2021 Nov; 9(11):e1539-e1552. PubMed ID: 34562369
[TBL] [Abstract][Full Text] [Related]
5. The Economic Costs of Type 2 Diabetes: A Global Systematic Review.
Seuring T; Archangelidi O; Suhrcke M
Pharmacoeconomics; 2015 Aug; 33(8):811-31. PubMed ID: 25787932
[TBL] [Abstract][Full Text] [Related]
6. Patient and Family Financial Burden in Cancer: A Focus on Differences across Four Provinces, and Reduced Spending Including Decisions to Forego Care in Canada.
Longo CJ; Maity T; Fitch MI; Young JT
Curr Oncol; 2024 May; 31(5):2713-2726. PubMed ID: 38785487
[TBL] [Abstract][Full Text] [Related]
7. Mexico's household health expenditure on diabetes and hypertension: What is the additional financial burden?
Gutierrez JP; Garcia-Saiso S; Aracena BM
PLoS One; 2018; 13(7):e0201333. PubMed ID: 30052668
[TBL] [Abstract][Full Text] [Related]
8. Challenges and dilemmas on universal coverage for non-communicable diseases in middle-income countries: evidence and lessons from Mexico.
Arredondo A; Azar A; Recaman AL
Global Health; 2018 Aug; 14(1):89. PubMed ID: 30143010
[TBL] [Abstract][Full Text] [Related]
9. An assessment of randomized controlled trials (RCTs) for non-communicable diseases (NCDs): more and higher quality research is required in less developed countries.
Fan H; Song F
Sci Rep; 2015 Aug; 5():13221. PubMed ID: 26272174
[TBL] [Abstract][Full Text] [Related]
10. Reimbursing live organ donors for incurred non-medical expenses: a global perspective on policies and programs.
Sickand M; Cuerden MS; Klarenbach SW; Ojo AO; Parikh CR; Boudville N; Garg AX;
Am J Transplant; 2009 Dec; 9(12):2825-36. PubMed ID: 19788503
[TBL] [Abstract][Full Text] [Related]
11. What affects the direct economic burden of non-communicable diseases on middle-aged and older adult people in Shaanxi Province?
Yang X; Yan J; Lai S; Shen C; Duan N
Front Public Health; 2023; 11():1219199. PubMed ID: 38186709
[TBL] [Abstract][Full Text] [Related]
12. Management of NCD in low- and middle-income countries.
Checkley W; Ghannem H; Irazola V; Kimaiyo S; Levitt NS; Miranda JJ; Niessen L; Prabhakaran D; Rabadán-Diehl C; Ramirez-Zea M; Rubinstein A; Sigamani A; Smith R; Tandon N; Wu Y; Xavier D; Yan LL;
Glob Heart; 2014 Dec; 9(4):431-43. PubMed ID: 25592798
[TBL] [Abstract][Full Text] [Related]
13. The increasing prevalence of non-communicable diseases in low-middle income countries: the view from Malawi.
Gowshall M; Taylor-Robinson SD
Int J Gen Med; 2018; 11():255-264. PubMed ID: 29988742
[TBL] [Abstract][Full Text] [Related]
14. Models of care for sickle cell disease in low-income and lower-middle-income countries: a scoping review.
Drown L; Osei M; Thapa A; Boudreaux C; Archer N; Bukhman G; Adler AJ
Lancet Haematol; 2024 Apr; 11(4):e299-e308. PubMed ID: 38432241
[TBL] [Abstract][Full Text] [Related]
15. Financial toxicity of cancer care in low- and middle-income countries: a systematic review and meta-analysis.
Donkor A; Atuwo-Ampoh VD; Yakanu F; Torgbenu E; Ameyaw EK; Kitson-Mills D; Vanderpuye V; Kyei KA; Anim-Sampong S; Khader O; Khader J
Support Care Cancer; 2022 Sep; 30(9):7159-7190. PubMed ID: 35467118
[TBL] [Abstract][Full Text] [Related]
16. Social capital is associated with improved subjective well-being of older adults with chronic non-communicable disease in six low- and middle-income countries.
Christian AK; Sanuade OA; Okyere MA; Adjaye-Gbewonyo K
Global Health; 2020 Jan; 16(1):2. PubMed ID: 31898527
[TBL] [Abstract][Full Text] [Related]
17. Assessing the future medical cost burden for the European health systems under alternative exposure-to-risks scenarios.
Goryakin Y; Thiébaut SP; Cortaredona S; Lerouge MA; Cecchini M; Feigl AB; Ventelou B
PLoS One; 2020; 15(9):e0238565. PubMed ID: 32915826
[TBL] [Abstract][Full Text] [Related]
18. The Challenges in the Development of Diabetes Prevention and Care Models in Low-Income Settings.
Karachaliou F; Simatos G; Simatou A
Front Endocrinol (Lausanne); 2020; 11():518. PubMed ID: 32903709
[TBL] [Abstract][Full Text] [Related]
19. Evaluating and Improving Cardiovascular Health System Management in Low- and Middle-Income Countries.
Yoo SGK; Prabhakaran D; Huffman MD
Circ Cardiovasc Qual Outcomes; 2017 Nov; 10(11):. PubMed ID: 29133473
[No Abstract] [Full Text] [Related]
20. Redesigning primary care to tackle the global epidemic of noncommunicable disease.
Kruk ME; Nigenda G; Knaul FM
Am J Public Health; 2015 Mar; 105(3):431-7. PubMed ID: 25602898
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
